Literature DB >> 29022925

Anti-cytomegalovirus immunoglobulin M titer for congenital infection in first-trimester pregnancy with primary infection: a multicenter prospective cohort study.

K Toriyabe1, F Morikawa2, T Minematsu3, M Ikejiri4, S Suga5, T Ikeda1.   

Abstract

OBJECTIVE: We evaluated cytomegalovirus (CMV) immunoglobulin M (IgM) titer in pregnant women with primary infection as a predictive factor for congenital infection. STUDY
DESIGN: Maternal CMV antibody screening during the first trimester was conducted prospectively at 16 centers in Japan between September 2013 and 2015. Women with confirmed maternal primary infection underwent testing for fetal congenital infection, and we investigated the positive predictive value of CMV IgM titer levels for congenital infection in women with a low IgG avidity.
RESULTS: We identified 6 (8.6%) cases of congenital infection among 70 pregnant women with positive/borderline IgG, positive IgM and IgG avidity index ⩽35.0% and 11 (39.3%) among 28 women with IgG and/or IgM seroconversion. IgM titer level ⩾6.00 index showed the highest positive predictive value (17.1%).
CONCLUSION: High titer of CMV IgM during the first trimester in pregnant women with primary infection is a risk factor for congenital infection.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29022925     DOI: 10.1038/jp.2017.133

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  24 in total

1.  Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels.

Authors:  Harry E Prince; Amy L Leber
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

2.  Prediction of Congenital Cytomegalovirus Infection in High-Risk Pregnant Women.

Authors:  Kenji Tanimura; Shinya Tairaku; Yasuhiko Ebina; Ichiro Morioka; Satoshi Nagamata; Kana Deguchi; Mayumi Morizane; Masashi Deguchi; Toshio Minematsu; Hideto Yamada
Journal:  Clin Infect Dis       Date:  2016-10-20       Impact factor: 9.079

3.  Single cytomegalovirus strain associated with fetal loss and then congenital infection of a subsequent child born to the same mother.

Authors:  Tsunehisa Nagamori; Shin Koyano; Naoki Inoue; Hideto Yamada; Miho Oshima; Toshio Minematsu; Kenji Fujieda
Journal:  J Clin Virol       Date:  2010-08-03       Impact factor: 3.168

4.  The combination of specific IgM antibodies and IgG antibodies of low avidity does not always indicate primary infection with cytomegalovirus.

Authors:  S Lumley; M Patel; P D Griffiths
Journal:  J Med Virol       Date:  2014-01-07       Impact factor: 2.327

5.  Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity.

Authors:  N K Blackburn; T G Besselaar; B D Schoub; K F O'Connell
Journal:  J Med Virol       Date:  1991-01       Impact factor: 2.327

6.  Changes in cytomegalovirus seroprevalence in pregnant Japanese women-a 10-year single center study.

Authors:  Kosuke Taniguchi; Noriyoshi Watanabe; Anna Sato; Seung Chik Jwa; Tomo Suzuki; Yuji Yamanobe; Haruhiko Sago; Kazuto Kozuka
Journal:  J Clin Virol       Date:  2014-01-08       Impact factor: 3.168

7.  A trial of immunoglobulin fetal therapy for symptomatic congenital cytomegalovirus infection.

Authors: 
Journal:  J Reprod Immunol       Date:  2012-08-11       Impact factor: 4.054

Review 8.  Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy.

Authors:  Harry E Prince; Mary Lapé-Nixon
Journal:  Clin Vaccine Immunol       Date:  2014-08-27

9.  Seroepidemiological survey of cytomegalovirus infection among pregnant women in Nagasaki, Japan.

Authors:  Masato Tagawa; Toshio Minematsu; Hideaki Masuzaki; Tadayuki Ishimaru; Hiroyuki Moriuchi
Journal:  Pediatr Int       Date:  2009-11-16       Impact factor: 1.524

10.  Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays.

Authors:  K Lagrou; M Bodeus; M Van Ranst; P Goubau
Journal:  J Clin Microbiol       Date:  2009-04-01       Impact factor: 5.948

View more
  4 in total

1.  The Immunoglobulin M-Shed Acute Phase Antigen (SAPA)-test for the Early Diagnosis of Congenital Chagas Disease in the Time of the Elimination Goal of Mother-to-Child Transmission.

Authors:  Yagahira E Castro-Sesquen; Freddy Tinajeros; Caryn Bern; Gerson Galdos-Cardenas; Edith S Malaga; Edward Valencia Ayala; Kathryn Hjerrild; Steven J Clipman; Andrés G Lescano; Tabitha Bayangos; Walter Castillo; María Carmen Menduiña; Kawsar R Talaat; Robert H Gilman
Journal:  Clin Infect Dis       Date:  2021-07-15       Impact factor: 9.079

Review 2.  Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays.

Authors:  Bettie Voordouw; Barry Rockx; Thomas Jaenisch; Pieter Fraaij; Philippe Mayaud; Ann Vossen; Marion Koopmans
Journal:  Clin Microbiol Rev       Date:  2019-12-11       Impact factor: 26.132

Review 3.  Pitfalls in the Serological Evaluation of Maternal Cytomegalovirus Infection as a Potential Cause of Fetal and Neonatal Involvements: A Narrative Literature Review.

Authors:  Shigeo Iijima
Journal:  J Clin Med       Date:  2022-08-26       Impact factor: 4.964

4.  A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development.

Authors:  Witold Lewandowski; Carla Talarico; Karen Fowler; Jacek Mucha; Monika Neumann; Magdalena Kaczanowska; Maciej Grys; Elvira Schmidt; Andrew Natenshon; Philip O Buck; John Diaz-Decaro
Journal:  BMC Public Health       Date:  2022-09-01       Impact factor: 4.135

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.